David Lewis

Active 1956–2025

378
Papers
60,840
Citations
112
h-index
253
i10-index

Citations

Citations per year for David Lewis1963: 2 citations1964: 1 citations1967: 2 citations1969: 1 citations1970: 6 citations1972: 3 citations1973: 4 citations1974: 4 citations1975: 4 citations1976: 6 citations1977: 3 citations1978: 10 citations1979: 5 citations1980: 17 citations1981: 15 citations1982: 11 citations1983: 20 citations1984: 21 citations1985: 14 citations1986: 19 citations1987: 19 citations1988: 21 citations1989: 40 citations1990: 45 citations1991: 32 citations1992: 60 citations1993: 61 citations1994: 72 citations1995: 73 citations1996: 115 citations1997: 96 citations1998: 121 citations1999: 142 citations2000: 169 citations2001: 230 citations2002: 203 citations2003: 293 citations2004: 279 citations2005: 386 citations2006: 363 citations2007: 398 citations2008: 332 citations2009: 321 citations2010: 378 citations2011: 355 citations2012: 372 citations2013: 336 citations2014: 405 citations2015: 370 citations2016: 412 citations2017: 354 citations2018: 353 citations2019: 638 citations2020: 539 citations2021: 570 citations2022: 495 citations2023: 515 citations2024: 771 citations2025: 503 citations2026: 38 citations1965–1966: no citations, so these years are not shown1968: no citations, so this year is not shown1971: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,277 citing papers, 25.9% of this breakdownUnited Kingdom: 1,304 citing papers, 10.3% of this breakdownGermany: 702 citing papers, 5.5% of this breakdownChina: 621 citing papers, 4.9% of this breakdownCanada: 589 citing papers, 4.7% of this breakdownItaly: 536 citing papers, 4.2% of this breakdownAustralia: 523 citing papers, 4.1% of this breakdownFrance: 508 citing papers, 4% of this breakdownNetherlands: 416 citing papers, 3.3% of this breakdownSpain: 356 citing papers, 2.8% of this breakdownJapan: 285 citing papers, 2.3% of this breakdownSweden: 245 citing papers, 1.9% of this breakdown
0%25.9%Other 26.1%

Fields

  • Computer Science30.5%
  • Medicine18.8%
  • Arts and Humanities13.6%
  • Psychology8.8%
  • Biochemistry, Genetics and Molecular Biology4.6%
  • Social Sciences4.3%
  • Other19.4%

Topics

  • Philosophy and Theoretical Science4.7%
  • Logic, Reasoning, and Knowledge4.7%
  • Epistemology, Ethics, and Metaphysics3.6%
  • Philosophy and History of Science2.4%
  • Syntax, Semantics, Linguistic Variation1.9%
  • Semantic Web and Ontologies1.8%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Epcoritamab, a Novel, Subcutaneous CD3xCD20 Bispecific T-Cell–Engaging Antibody, in Relapsed or Refractory Large B-Cell Lymphoma: Dose Expansion in a Phase I/II Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 cited by 523

  2. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins - The Lancet 2011 cited by 2,466

  3. Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2021 cited by 337

  4. Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle A. Detry, Christina Saunders, Mark Fitzgerald, Nicholas Berry, Lazaro Mwandigha, Ushma Galal, Sam Mort, Bhautesh Jani, Nigel Hart, Haroon Ahmed, Daniel Butler, Micheal McKenna, Jem Chalk, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique Andersson, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Andrew Carson‐Stevens, Ly‐Mee Yu, Paul Little, Akosua Adom Agyeman, Tanveer Ahmed, Damien Allcock, Adrian Beltran-Martinez, Oluseye E Benedict, Nigel C. Bird, Laura K. Brennan, Julianne R. Brown, Gerard P. Burns, Mike Butler, Zelda Cheng, Ruth Danson, Nigel de Kare-Silver, Devesh Dhasmana, Jon M Dickson, Serge Engamba, Stacey Fisher, Robin Fox, Eve Frost, Richard A. Gaunt, Sarit K. Ghosh, Ishtiaq A Gilkar, Anna L. Goodman, Steve Granier, Aleksandra Howell, Iqbal Hussain, Simon M. Hutchinson, Marie Imlach, Greg Irving, Nicholas Jacobsen, James Kennard, Umar Khan, Kyle Knox, Christopher Krasucki, Tom Law, Rem Lee, Nicola Lester, David Lewis, J.A. Lunn, Claire I. Mackintosh, Mehul Mathukia, Patrick S. Moore, Seb Morton and 35 more - The Lancet 2022 cited by 406

  5. Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew S. Davids, Xuan Tan, Timothy S. Fenske, Johan Wallin, Donald E. Tsai, Nora Ku, Edward Y. Zhu, Jessica Chen, Ming Yin, Binoj C. Nair, Kevin Ebata, Narasimha Marella, Jennifer R. Brown, Michael Wang - The Lancet 2021 cited by 454

  6. Ethics and diversity in artificial intelligence policies, strategies and initiatives

    Authors: , , - AI and Ethics, AI Ethics 2022 cited by 164

  7. Epcoritamab monotherapy in patients with relapsed or refractory follicular lymphoma (EPCORE NHL-1): a phase 2 cohort of a single-arm, multicentre study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Haematology 2024 cited by 139

  8. Hypoxia shapes the immune landscape in lung injury and promotes the persistence of inflammation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lara Campana, Philip Starkey Lewis, A. John Simpson, David H. Dockrell, Jürgen Schwarze, Nikhil Hirani, Peter J. Ratcliffe, Christopher W. Pugh, Kamil R. Kranc, Stuart J. Forbes, Moira K. B. Whyte, Sarah R. Walmsley - Nature Immunology 2022 cited by 80

  9. Feature selection and feature extraction for text categorization

    Authors: - workshop on Speech and Natural Language - HLT '91, Proceedings of the workshop on Speech and Natural Language - HLT '91 1992 cited by 584

  10. Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Infectious Diseases 2019 cited by 205

  11. Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Finlayson, Anthony D. Kelleher, Kenneth Koh, David Lewis, James McMahon, Richard Moore, Norman Roth, Matt Shields, Stéphane De Wit, Éric Florence, Jean‐Christophe Goffard, Rémy Demeester, Patrick Lacor, Bernard Vandercam, Linos Vandekerckhove, Jonathan B. Angel, Jean‐Guy Baril, Brian Conway, Alexandra de Pokomandy, Jason Szabo, Sharon Walmsley, Olivier Bouchaud, Christian Chidiac, Pierre Delobel, Cécile Goujard, Christine Katlama, Jean‐Michel Molina, Gilles Pialoux, Patrick Philibert, Johannes R. Bogner, Stefan Esser, Ivanka Krznaric, Clara Lehmann, Christoph D. Spinner, Hans‐Jürgen Stellbrink, Christoph Stephan, Albrecht Stoehr, Enrico Barchi, Pietro Caramello, Francesco Castelli, Anna Maria Cattelan, Antonella D'Arminio Monforte, Antonio Di Biagio, Giovanni Di Perri, Andrea Gori, Franco Maggiolo, Barbara Menzaghi, Guglielmo Marco Migliorino, Cristina Mussini, Giovanni Penco, Massimo Puoti, Giuliano Rizzardini, Roberto Gulminetti, Adriano Lazzarin, Tiziano Quirino, Laura Sighinolfi, Pierluigi Viale, Gerardo Amaya Tapia, Jaime Andrade‐Villanueva, Enrique R Granados Reyes, Alma Perez Rios, Mario Santoscoy Gomez, Jan den Hollander, Bart Rijnders, José A. Hidalgo, Luis Hercilla Vásquez, Luis Ricardo Illescas, Anita Olczak, Kamal Mansinho, Patrícia Pacheco and 109 more - The Lancet 2018 cited by 381

  12. Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Martin Dreyling - New England Journal of Medicine 2022 cited by 216

  13. Adeno-associated virus vectored immunoprophylaxis to prevent HIV in healthy adults: a phase 1 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet HIV 2019 cited by 134

  14. Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Leukemia 2024 cited by 119

  15. Pirtobrutinib in Covalent Bruton Tyrosine Kinase Inhibitor Pretreated Mantle-Cell Lymphoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Minna Balbas, Richard A. Walgren, Paolo Abada, Chunxiao Wang, Junjie Zhao, Anthony R. Mato, Nirav N. Shah - Journal of Clinical Oncology 2023 cited by 106

  16. Initial Findings from a First-in-Human Phase 1a/b Trial of NX-5948, a Selective Bruton's Tyrosine Kinase (BTK) Degrader, in Patients with Relapsed/Refractory B Cell Malignancies

    Authors: , , , , , , , , , , , , , , , - Blood 2023 cited by 32

  17. Examining the relationship among student perception of support, course satisfaction, and learning outcomes in online learning

    Authors: , , , , - The Internet and Higher Education, Internet High. Educ. 2011 cited by 413

  18. Brexanolone, a GABAA Modulator, in the Treatment of Postpartum Depression in Adults: A Comprehensive Review

    Authors: , , , , , , , , , , , , - Frontiers in Psychiatry 2021 cited by 94

  19. Counterfactual Dependence and Time's Arrow

    Authors: - Noûs 1979 cited by 1,603

  20. Safety Profile and Immunologic Responses of a Novel Vaccine Against Shigella sonnei Administered Intramuscularly, Intradermally and Intranasally: Results From Two Parallel Randomized Phase 1 Clinical Studies in Healthy Adult Volunteers in Europe

    Authors: , , , , , , , , , , , , , , , , , , - EBioMedicine 2017 cited by 112

  21. Scorekeeping in a language game

    Authors: - Formal Semantics, J. Philos. Log. 1979 cited by 2,440

  22. Effects of Lowering LDL Cholesterol on Progression of Kidney Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lawrence Y. Agodoa, Mike Gaziano, Bertram L. Kasiske, Rob Walker, Ziad A. Massy, Bo Feldt‐Rasmussen, Udom Krairittichai, Vuddidhej Ophascharoensuk, Bengt Fellström, Hallvard Holdaas, Vladimı́r Tesař, Andrzej Więcek, Diederick E. Grobbee, Dick de Zeeuw, Carola Grönhagen‐Riska, Tanaji Dasgupta, David Lewis, William G. Herrington, Marion Mafham, William Majoni, Karl Wallendszus, Richard H. Grimm, Terje Pedersen, Jonathan A. Tobert, Jane Armitage, Alex Baxter, Christopher Bray, Yiping Chen, Zhengming Chen, Michael Hill, Carol Knott, Sarah Parish, David Simpson, Peter Sleight, Alan Young, Rory Collins - Journal of the American Society of Nephrology 2014 cited by 177

  23. Attitudes De Dicto and De Se

    Authors: - The Philosophical Review 1979 cited by 1,914

  24. Reuters-21578 Text Categorization Collection

    Authors: - 1987 cited by 19